From: Strategies for enhancing the representation of women in clinical trials: an evidence map
Article characteristics | n = number of articles unless otherwise indicated |
---|---|
Total number articles included (#trials described) | 122 (136)a |
Total number of women recruited (total N; median; range per study) | 377,595b; 285; (1–202,638)c |
Total number of articles reporting an a priori recruitment target | 52 |
Population recruited | |
Women only | 116 |
Couples only | 1 |
Women and children | 2 |
Men or women (individually) | 3 |
Site of recruitment efforts by country | |
United States | 78 |
United Kingdom | 13 |
Australia | 11 |
Canada | 6 |
>1 Country | 7 |
Other | 7 |
Methodologic approachd | |
Descriptive | 58 |
Compared strategies | 72 |
Primary qualitative | 10 |
Target condition for trial (women-specific) | |
Peripartum | 37 |
Cancer | 27 |
Menopause | 10 |
Gynecologic conditions | 9 |
General women’s health | 3 |
Urogynecologic | 3 |
Cancer prevention | 1 |
Contraception | 1 |
Infectious diseases | 1 |
Target condition for trial (not women-specific) | |
Metabolic health | 7 |
Infectious disease | 6 |
Bone health | 4 |
Cardiovascular disease | 4 |
Mental health | 3 |
Nutrition | 2 |
Cancer survivorship | 1 |
Interpersonal violence | 1 |
Not specified | 1 |
Partner health | 1 |
Intervention typed | |
Behavioral | 63 |
Invasive | 5 |
Pharmacologic | 28 |
Multiple | 13 |
Other | 13 |
Virtual intervention component | 28 |
Recruitment/retention strategies described by phasee | |
Trial development | 56 |
Potential participant outreach | 116 |
Enrollment/consent process | 40 |
Intervention delivery | 76 |
Outcomes assessment | 21 |
Analysis and interpretation | 3 |
Dissemination | 4 |
Race or ethnic group of interest | |
Asian | 2 |
Black or African American only | 19 |
Latina only | 5 |
Native Hawaiian or other Pacific Islander only | 1 |
Multiple racial/ethnic minoritized populations | 14 |
No focus on recruiting a specific racial or ethnic group | 81 |
Rural/urban | |
Urban populations | 15 |
Rural populations | 9 |
Age groupsf | |
Studies that include participants <18 years | 7 |
Total age range (years) | 12–70 |
Studies that include participants >50 years | 38* |